
    
      The intervention will be delivered through telemedicine to reduce the patient-related
      barriers to treatment including cost, transportation, and being able to maintain appointments
      while managing the side effects of treatment. The intervention will provide the patient with
      skills to reduce distress associated with ceasing treatment of a checkpoint inhibitor through
      the development evidence-based psychological and behavioral strategies that are tailored to
      the patients' preferences.
    
  